SI1112738T1 - Stabilen oralni dozirni sestavek s podaljšanim sproščanjem, ki obsega psevdoefedrin in desloratadin - Google Patents

Stabilen oralni dozirni sestavek s podaljšanim sproščanjem, ki obsega psevdoefedrin in desloratadin

Info

Publication number
SI1112738T1
SI1112738T1 SI200031059T SI200031059T SI1112738T1 SI 1112738 T1 SI1112738 T1 SI 1112738T1 SI 200031059 T SI200031059 T SI 200031059T SI 200031059 T SI200031059 T SI 200031059T SI 1112738 T1 SI1112738 T1 SI 1112738T1
Authority
SI
Slovenia
Prior art keywords
desloratadine
pseudoephedrine
oral dosage
extended release
release oral
Prior art date
Application number
SI200031059T
Other languages
English (en)
Inventor
Jim H Kou
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22629437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1112738(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of SI1112738T1 publication Critical patent/SI1112738T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SI200031059T 1999-12-20 2000-12-20 Stabilen oralni dozirni sestavek s podaljšanim sproščanjem, ki obsega psevdoefedrin in desloratadin SI1112738T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17283699P 1999-12-20 1999-12-20
EP00311445A EP1112738B1 (en) 1999-12-20 2000-12-20 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine

Publications (1)

Publication Number Publication Date
SI1112738T1 true SI1112738T1 (sl) 2010-07-30

Family

ID=22629437

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200031059T SI1112738T1 (sl) 1999-12-20 2000-12-20 Stabilen oralni dozirni sestavek s podaljšanim sproščanjem, ki obsega psevdoefedrin in desloratadin

Country Status (38)

Country Link
US (2) US6979463B2 (sl)
EP (2) EP2196195A3 (sl)
JP (3) JP5042403B2 (sl)
KR (2) KR100936572B1 (sl)
CN (3) CN101081224B (sl)
AR (1) AR027033A1 (sl)
AT (1) ATE463240T1 (sl)
AU (4) AU2277101A (sl)
BR (1) BR0006403A (sl)
CA (1) CA2329217C (sl)
CO (1) CO5251435A1 (sl)
CY (1) CY1110693T1 (sl)
CZ (1) CZ302860B6 (sl)
DE (1) DE60044117D1 (sl)
DK (1) DK1112738T3 (sl)
EC (1) ECSP003836A (sl)
EG (1) EG23759A (sl)
ES (1) ES2341751T3 (sl)
HK (1) HK1034453A1 (sl)
HU (1) HUP0004988A3 (sl)
ID (1) ID28675A (sl)
IL (1) IL140450A (sl)
MX (1) MXPA00013037A (sl)
MY (1) MY130773A (sl)
NO (1) NO331645B1 (sl)
NZ (1) NZ509028A (sl)
PE (1) PE20010982A1 (sl)
PL (1) PL211573B1 (sl)
PT (1) PT1112738E (sl)
RU (2) RU2303440C2 (sl)
SA (2) SA06270069B1 (sl)
SG (1) SG109438A1 (sl)
SI (1) SI1112738T1 (sl)
SK (1) SK287684B6 (sl)
TR (1) TR200003787A3 (sl)
TW (1) TWI225414B (sl)
WO (1) WO2001045668A2 (sl)
ZA (1) ZA200007715B (sl)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
SK287105B6 (sk) 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
JP2004534820A (ja) * 2001-06-20 2004-11-18 シェーリング　コーポレイション 鼻うっ血および鼻閉塞の処置のための抗ヒスタミン薬
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
PT1476138E (pt) 2002-02-21 2012-02-14 Valeant Internat Barbados Srl Formulações de libertação modificada de pelo menos uma forma de tramadol
ES2232331T1 (es) * 2003-03-12 2005-06-01 Biogal Gyogyszergyar Rt. Procedimientos para la preparacion de formas polimorficas de desloratadina.
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
EP1700591A4 (en) * 2003-12-01 2011-08-03 Takeda Pharmaceutical PROCESS FOR TREATING SOLID PHARMACEUTICAL PREPARATION PRIOR TO PRINTING AND SOLID PHARMACEUTICAL PREPARATION SUBJECT TO PROCESSING BEFORE PRINTING
WO2006047427A1 (en) * 2004-10-25 2006-05-04 Schering Corporation M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20070014855A1 (en) * 2005-07-12 2007-01-18 Rahul Gawande S Stable desloratadine compositions
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US7827042B2 (en) 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20080210748A1 (en) 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
FR2894143B1 (fr) 2005-12-01 2008-05-02 Pierre Fabre Medicament Sa Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
CA2653955C (en) * 2006-06-01 2015-10-27 Schering Corporation Pharmaceutical compositions for sustained release of phenylephrine
KR20090015103A (ko) * 2006-06-01 2009-02-11 쉐링 코포레이션 페닐에프린 펄스 방출 제형 및 약제학적 조성물
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
WO2007143158A2 (en) * 2006-06-01 2007-12-13 Schering-Plough Healthcare Products, Inc. Sustained release pharmaceutical formulation comprising phenylephrine
JP2009543780A (ja) * 2006-07-11 2009-12-10 ミューチュアル ファーマシューティカル カンパニー，インク． 制御放出製剤およびキット
US20080299186A1 (en) * 2007-06-01 2008-12-04 Schering-Plough Healthcare Products, Inc. Coatings for applying substances onto substrate carrier
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
WO2010143202A1 (en) * 2009-06-09 2010-12-16 Sun Pharmaceutical Industries Ltd. Pharmaceutical composition
TR201009396A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Desloratadin granüller
DE102016107760B4 (de) 2016-04-26 2018-09-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Essbare Funktionsschichten und Überzüge auf Hybridpolymerbasis für Pharmazie und Lebensmittel
US10463656B2 (en) 2017-01-05 2019-11-05 Iowa State University Research Foundation, Inc. Methods and compositions for prevention of feedlot bovine respiratory disease
CR20230109A (es) 2020-07-30 2023-05-11 Faes Farma Sa Sistema de liberación de fármacos descongestivos y bilastina

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US100000A (en) 1870-02-22 Improved sun-bonnet for horses
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3940485A (en) 1973-12-12 1976-02-24 Levinson Harold N Treatment and pre-treatment of dysmetric dyslexia by improving sequential scanning and ocular fixation abilities and therapeutic compounds
US4008796A (en) 1974-03-26 1977-02-22 General Concrete Of Canada Limited Control method for feeding items on a conveyor
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4282233B1 (en) 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
JPS61501205A (ja) 1984-02-15 1986-06-19 シェリング・コ−ポレ−ション ８↓−クロル↓−６，１１↓−ジヒドロ↓−１１↓−（４↓−ピペリジリデン）↓−５Ｈ↓−ベンゾ〔５，６〕シクロヘプタ〔１，２−ｂ〕ピリジンおよびその塩、これらの化合物の製造方法、ならびにこれらの化合物を含有する医薬組成物
US4783465A (en) 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
SE8404467D0 (sv) 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
US4731447A (en) 1985-05-13 1988-03-15 Schering Corporation Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof
US4804666A (en) * 1985-08-14 1989-02-14 Schering Corporation Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
JPS6396126A (ja) * 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4777170A (en) 1987-02-03 1988-10-11 Heinrich William A Method to prevent and treat the signs and symptoms of motion sickness
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4863931A (en) * 1988-09-15 1989-09-05 Schering Corporation Antihistaminic fluoro substituted benzocycloheptapyridines
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
US4990535A (en) 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
IL98572A (en) 1990-06-22 1995-07-31 Schering Corp Bite-benzo or benzopyrido compounds Cyclohepta piperidine, piperidylidene and piperazine, preparations and methods of use.
US5416091A (en) 1990-12-18 1995-05-16 Burroughs Wellcome Co. Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
PT100502A (pt) 1991-05-20 1993-08-31 Alza Corp Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
US5266331A (en) 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
US5314697A (en) 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
IT1264517B1 (it) 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
JP2646972B2 (ja) 1993-11-01 1997-08-27 日本電気株式会社 多ビットメモリ
DE4442999A1 (de) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US5807579A (en) * 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
TR199901003T2 (xx) * 1996-10-31 1999-07-21 Schering Corporation Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im.
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US6506767B1 (en) * 1997-07-02 2003-01-14 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
CA2307790A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
PT1380297E (pt) 1998-07-10 2009-07-06 Schering Corp Composições orais de 8-cloro-6,11-di-hidro-11-(4- piperidilideno)-5h-benzo[5,6]ciclo-hepta[1,2-b]piridina
US6423721B1 (en) 1998-09-10 2002-07-23 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6521254B2 (en) * 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6100274A (en) 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
SK287105B6 (sk) 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
CA2398261A1 (en) 2000-02-03 2001-08-09 Schering Corporation Treating allergic and inflammatory conditions
EP1289945B1 (en) 2000-05-19 2004-08-04 Alcon Inc. Aniline disulfide derivatives for treating allergic diseases
US6599913B1 (en) 2001-06-29 2003-07-29 Schering Corporation Treating allergic and inflammatory conditions

Also Published As

Publication number Publication date
BR0006403A (pt) 2001-07-17
AU2009200460A1 (en) 2009-02-26
AU2005203771A1 (en) 2005-09-15
ES2341751T3 (es) 2010-06-28
CY1110693T1 (el) 2015-06-10
PT1112738E (pt) 2010-06-04
HK1034453A1 (en) 2001-10-26
WO2001045668A3 (en) 2001-12-13
CA2329217C (en) 2006-10-31
KR101234940B1 (ko) 2013-02-19
EP1112738A3 (en) 2001-07-18
EP1112738A2 (en) 2001-07-04
US20060159761A1 (en) 2006-07-20
SA06270069B1 (ar) 2009-06-07
DE60044117D1 (de) 2010-05-20
SA01210741A (ar) 2005-12-03
EP2196195A3 (en) 2012-02-29
KR100936572B1 (ko) 2010-01-13
JP2001172174A (ja) 2001-06-26
US20030086971A1 (en) 2003-05-08
US6979463B2 (en) 2005-12-27
RU2007104095A (ru) 2008-08-10
NO20006504D0 (no) 2000-12-20
HUP0004988A2 (hu) 2002-11-28
WO2001045668A2 (en) 2001-06-28
US7820199B2 (en) 2010-10-26
CN1301534A (zh) 2001-07-04
RU2423106C2 (ru) 2011-07-10
JP2012224642A (ja) 2012-11-15
NZ509028A (en) 2002-12-20
ATE463240T1 (de) 2010-04-15
MY130773A (en) 2007-07-31
CO5251435A1 (es) 2003-02-28
IL140450A (en) 2011-11-30
CN101081224B (zh) 2012-05-30
RU2423106C9 (ru) 2012-06-27
EP1112738B1 (en) 2010-04-07
TWI225414B (en) 2004-12-21
ZA200007715B (en) 2001-06-20
AU2277101A (en) 2001-07-03
ECSP003836A (es) 2002-02-25
KR20110028326A (ko) 2011-03-17
JP5042403B2 (ja) 2012-10-03
NO20006504L (no) 2001-06-21
CZ20004812A3 (cs) 2001-08-15
SK19672000A3 (sk) 2001-09-11
PL211573B1 (pl) 2012-05-31
TR200003787A2 (tr) 2001-07-23
MXPA00013037A (es) 2003-06-19
SK287684B6 (sk) 2011-06-06
CN1211079C (zh) 2005-07-20
KR20010062542A (ko) 2001-07-07
AU2009200460B2 (en) 2012-01-19
CA2329217A1 (en) 2001-06-20
AR027033A1 (es) 2003-03-12
IL140450A0 (en) 2002-02-10
EG23759A (en) 2007-08-08
CZ302860B6 (cs) 2011-12-21
PE20010982A1 (es) 2001-09-28
TR200003787A3 (tr) 2001-07-23
HU0004988D0 (sl) 2001-02-28
ID28675A (id) 2001-06-21
EP2196195A2 (en) 2010-06-16
CN1679569A (zh) 2005-10-12
HUP0004988A3 (en) 2008-04-28
SA01210741B1 (ar) 2006-10-31
NO331645B1 (no) 2012-02-13
DK1112738T3 (da) 2010-06-28
RU2303440C2 (ru) 2007-07-27
JP2008081510A (ja) 2008-04-10
CN101081224A (zh) 2007-12-05
SG109438A1 (en) 2005-03-30
PL344715A1 (en) 2001-07-02
AU7244300A (en) 2001-06-21
AU781924B2 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
HK1034453A1 (en) Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
HK1090840A1 (en) Extended release oral dosage composition
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
AU6089200A (en) Rapid immediate release oral dosage form
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
IL136901A0 (en) Flash-melt oral dosage formulation
IL136827A0 (en) Oral pharmaceutical extended release dosage form
HUP0202495A3 (en) Stable medicinal compositions for oral use
HUP0203121A3 (en) Pharmaceutical composition containing substituted benzimidazoles and its use
EG22491A (en) Rest-breaking composition and use thereof
IL153487A0 (en) Pharmaceutical compositions and methods for use
HUP0201914A3 (en) Oral care composition
IL153897A0 (en) Pharmaceutical compositions and methods for use
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
GB9911606D0 (en) Composition and use
GB9923431D0 (en) Pharmaceutical compositions and their use
IL132006A0 (en) Stable pharmaceuticl oral dosage forms
SE9904414D0 (sv) Pharmaceutical composition and use
GB0018388D0 (en) Pharmaceutically effective compounds and their use
GB9907151D0 (en) Therapeutic antibody composition and use
GB9901682D0 (en) Therapeutic antibody composition and use
GB9906754D0 (en) Therapeutic antibody composition and use
GB9901689D0 (en) Therapeutic antibody composition and use
GB9925069D0 (en) Oral dosage form
HUP0203182A3 (en) Diaryl-enynes pharmaceutical compositions containing them and their use